Search Contract Forecasts

Tissue culture, sequencing, and immunological reagents

Type: Forecast

Overview

Description
Tissue culture, sequencing, and immunological reagents; RNA Sequencing; SBA, OPA; Human carriage kits; Tissue Culture and Immunoassay supplies; Priority 2, new requirement
Est. Value
Min: $25,000
Max: $250,000
Est. Award Date
27-Apr Future Opp
Source Est. Solicitation Date
27-Jan
Set Aside
To be determined
Forecast Type
New
Place of Performance
USA
Forecast Source
Department of Health and Human Services
Food and Drug Administration is forecasted to issue a new procurement for Tissue culture, sequencing, and immunological reagents around 27-Apr worth up to $250,000.

Agency

Source Level 1 Agency
Department of Health and Human Services
Source Level 2 Agency
FDA

Contacts

Point of Contact
CBER Acquisition Liaison   Profile
Point of Contact Email

Potential Bidders and Partners

Similar Active Opportunities

Additional Detail

Date Published
11/6/26
Date Modified
11/7/26
Additional Notes
Program Office: 75F401; Contracting Office: 75F402